The use of 1st class antiarrhythmics in modern therapy of cardiac arrhythmias

Tsaregorodtsev D.A.; Okisheva E.A.; Sulimov V.A.

doi:https://doi.org/

Tsaregorodtsev D.A.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Okisheva E.A.

GBOU VPO Pervyĭ MGMU im. I.M. Sechenova Minzdrava Rossii

Sulimov V.A.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

The use of 1st class antiarrhythmics in modern therapy of cardiac arrhythmias

Authors:

Tsaregorodtsev D.A., Okisheva E.A., Sulimov V.A.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(6): 54‑57

Read: 4613 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Tsaregorodtsev DA, Okisheva EA, Sulimov VA. The use of 1st class antiarrhythmics in modern therapy of cardiac arrhythmias. Russian Journal of Cardiology and Cardiovascular Surgery. 2012;5(6):54‑57. (In Russ.)

Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)

Использование инфографики авторами научных работ

Close metadata

Abstract:

Keywords:

cardiac arrhythmia

1st class antiarrhythmics

Authors:

Tsaregorodtsev D.A.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Okisheva E.A.

GBOU VPO Pervyĭ MGMU im. I.M. Sechenova Minzdrava Rossii

Sulimov V.A.

Pervyĭ MGMU im. I.M. Sechenova;
Moskovskiĭ NII pediatrii i detskoĭ khirurgii

Close metadata

References:

Bunin Yu.A., Fedyakina L.F. Kombinirovannaya profilakticheskaya antiaritmicheskaya farmakoterapiya fibrillyatsii i trepetaniya predserdii. Ros kardiol zhurn 2006; 6: 35-46.
Diagnostika i lechenie fibrillyatsii predserdii. Rekomendatsii VNOK i VNOA, 2011 g. Ratsion farmakoter v kardiol 2011; 7 (1-2): 3-66 (prilozhenie).
Dobrovol'skii A.V. Etatsizin - novyi vzglyad na otechestvennyi antiaritmicheskii preparat. Kardiol i serdechno-sosud khir 2010; 5: 97-105.
Zamotaev Yu.N., Kremnev Yu.A., Grinenko N.A., Podshibyakin S.E. Otsenka antiaritmicheskoi effektivnosti preparata allapinin u bol'nykh IBS s narusheniyami ritma serdtsa pri ispol'zovanii sutochnogo EKG-monitorirovaniya v kachestve informativnogo metoda kontrolya. Rus med zhurn 2003; 9: 518-521.
Miller O.N., Starichkov S.A., Pozdnyakov Yu.M i dr. Effektivnost' i bezopasnost' primeneniya propafenona (propanorma) i amiodarona (kordarona) u bol'nykh s fibrillyatsiei predserdii na fone arterial'noi gipertonii, ishemicheskoi bolezni serdtsa i khronicheskoi serdechnoi nedostatochnosti s sokhranennoi sistolicheskoi funktsiei levogo zheludochka. Mnogotsentrovoe, otkrytoe, randomizirovannoe prospektivnoe, sravnitel'noe issledovanie PROSTOR. Ros kardiol zhurn 2010; 4: 56-72.
Nedostup A.V., Blagova O.V. Etatsizin: mesto v lechenii aritmii. Kardiol i serdechno-sosud khir 2009; 4: 62-68.
Radzevich A.E., Konyakhin A.Yu., Kameneva T.R. i dr. Mesto etatsizina v terapii fibrillyatsii predserdii. Kardiologiya 2005; 1: 206-213.
Tsaregorodtsev D.A. Problema medikamentoznorezistentnykh aritmii. Ros kardiol zhurn 2001; 2: 68-75
ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol 2006; 48: 1064-1108.
Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. The Cardiac Arrhythmia Suppression Trial II Investigators. N Engl J Med 1992; 327 (4): 227-233.
Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace 2010; 12: 1360-1420.
Sanchez P.L., Fernandez-Aviles F. Structural heart disease: a new chapter in cardiovascular disease. ESC Monographic issue: Structural Heart Disease. Ed. C.E. Ruiz. Eur Heart J 2010; 12: Suppl E: e1.
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 321 (6): 406-412.